Intuitive Surgical shares slide 12% on growth outlook

• Intuitive Surgical shares fell more than 12% before the bell after the company maintained its worldwide procedure-growth forecast.
• The decline came despite Q2 adjusted EPS and revenue exceeding analysts’ estimates.
• Intuitive said insurance coverage and premium changes may be delaying some procedures that patients can defer.

Intuitive Surgical (NASDAQ:ISRG) shares fell more than 12% after the company maintained 13.5%–15.5% procedure-growth guidance and flagged insurance pressure.

U.S. da Vinci procedure growth slowed to 12% in Q2, its weakest rate in three years, while worldwide volume increased 15%.

“In our customer conversations, some have said changes in patient coverage and premium dynamics may be affecting when patients seek care,” said Intuitive Surgical CEO David Rosa.

Adjusted EPS reached $2.80 versus $2.50 expected, while revenue of $2.89 billion topped the $2.82 billion consensus.

Following the announcement, Intuitive Surgical's share price was down 11.26% at $357.02 in the latest verified premarket quote.

Intuitive placed 468 da Vinci systems, including 246 da Vinci 5 units, while Ion procedure volume increased 36%.

The company raised its 2026 adjusted gross-margin forecast to 68%–69%, but expects procedure growth near the midpoint of its maintained range.